HeartFlow, Inc. operates at the intersection of artificial intelligence and healthcare, focusing on non-invasive cardiovascular diagnostics. The company's core offering, the HeartFlow Platform, includes software products such as HeartFlow FFRCT Analysis, HeartFlow Plaque Analysis, and HeartFlow RoadMap Analysis. These tools leverage AI and computational fluid dynamics to transform single coronary computed tomography angiography (CTA) scans into precision 3D models, providing clinicians with actionable insights on blood flow, stenosis, and plaque. Operating primarily in the United States and Europe, HeartFlow serves hospitals and healthcare providers seeking to improve diagnostic accuracy and patient outcomes. By replacing invasive diagnostic procedures with software-driven analysis, the company aims to establish its technology as the definitive standard of care for coronary artery disease management.
